Increased plasma levels of asymmetric dimethylarginine in patients with carotid stenosis: no evidence for the role of the common FABP2 A54T gene polymorphism.

doi:10.1111/j.1600-0404.2006.00764.x

Article

Increased plasma levels of asymmetric dimethylarginine in patients with carotid stenosis: no evidence for the role of the common FABP2 A54T gene polymorphism.

Acta neurologica Scandinavica - 1 Feb 2007

Wanby P, Nilsson I, Brudin L, Nyhammar I, Gustafsson I, Carlsson M

Abstract excerpt

OBJECTIVE: Both asymmetric dimethylarginine (ADMA), which is an inhibitor of endothelial nitric oxide synthase and the fatty acid-binding protein 2 (FABP2) A54T gene polymorphism have been associated with cerebrovascular disease. The objective of the present study was to investigate the role of ADMA and the FABP2 A54T polymorphism in carotid atherosclerosis. MATERIAL AND METHODS: 54 patients with severe carotid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Increased plasma levels of asymmetric dimethylarginine in patients with carotid stenosis: no evidence for the role of the common FABP2 A54T gene polymorphism.

Abstract excerpt

Topics

Related research